NICE Ltd vs Twist Bioscience Corp — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: NICE Ltd and Twist Bioscience Corp are close in size by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, NICE Ltd nearer its low. Which is the better fit depends on your goals.
| NICE | TWST | |
|---|---|---|
Market Cap | $5.91B | $5.45B |
Sector | Technology | Health |
52-Week High | $170.37 | $102.88 |
52-Week Low | $83.15 | $24.16 |
Enterprise Value | $5.69B | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →